DNA X announces private placement of 1,346,531 Series B preferred shares for USD 8.1 million
DNA X
DNA X SONM | 0.00 |
- DNA X entered a private placement to sell 1,346,531 shares of non-voting Series B Convertible Preferred Stock at USD 6 per share.
- Transaction size USD 8.1 million, comprised of USD 5 million cash, cancellation of USD 3.1 million on a May 2026 convertible promissory note.
- Buyer DNA Holdings Venture, an affiliate of director Scott Walker, holds more than 5% of the outstanding stock.
- Series B converts automatically to common stock after shareholder approval, at an initial conversion price equal to stated value.
- Unregistered offering under Securities Act exemptions; proceeds earmarked for working capital, general corporate purposes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031675), on July 02, 2026, and is solely responsible for the information contained therein.
